Previous close | 10.73 |
Open | 10.77 |
Bid | 10.38 x 200 |
Ask | 10.47 x 100 |
Day's range | 10.42 - 10.81 |
52-week range | 6.88 - 13.77 |
Volume | |
Avg. volume | 180,222 |
Market cap | 331.415M |
Beta (5Y monthly) | 0.49 |
PE ratio (TTM) | 45.35 |
EPS (TTM) | 0.23 |
Earnings date | 25 Jul 2024 - 29 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 05 Jan 2022 |
1y target est | 19.88 |
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, announced it will present at the upcoming RBC Capital Markets Global Healthcare Conference, which is being held May 14-15, 2024.
Zynex (ZYXI) is well positioned to outperform the market, as it exhibits above-average growth in financials.